Ryan A. Irvine, Ph.D. - Publications

Affiliations: 
2000 University of Southern California, Los Angeles, CA, United States 
Area:
Molecular Biology, Oncology, Immunology

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2004 Buchanan G, Yang M, Cheong A, Harris JM, Irvine RA, Lambert PF, Moore NL, Raynor M, Neufing PJ, Coetzee GA, Tilley WD. Structural and functional consequences of glutamine tract variation in the androgen receptor. Human Molecular Genetics. 13: 1677-92. PMID 15198988 DOI: 10.1093/Hmg/Ddh181  0.649
2003 Clark PE, Irvine RA, Coetzee GA. The androgen receptor CAG repeat and prostate cancer risk. Methods in Molecular Medicine. 81: 255-66. PMID 12725125 DOI: 10.1385/1-59259-372-0:255  0.667
2002 Coetzee G, Irvine R. Size of the androgen receptor CAG repeat and prostate cancer: does it matter? Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 20: 3572-3. PMID 12202654 DOI: 10.1200/Jco.2002.20.17.3572  0.668
2001 Buchanan G, Irvine RA, Coetzee GA, Tilley WD. Contribution of the androgen receptor to prostate cancer predisposition and progression. Cancer Metastasis Reviews. 20: 207-23. PMID 12085963 DOI: 10.1023/A:1015531326689  0.681
2000 Park JJ, Irvine RA, Buchanan G, Koh SS, Park JM, Tilley WD, Stallcup MR, Press MF, Coetzee GA. Breast cancer susceptibility gene 1 (BRCAI) is a coactivator of the androgen receptor. Cancer Research. 60: 5946-9. PMID 11085509  0.625
2000 Xue W, Irvine RA, Yu MC, Ross RK, Coetzee GA, Ingles SA. Susceptibility to prostate cancer: interaction between genotypes at the androgen receptor and prostate-specific antigen loci. Cancer Research. 60: 839-41. PMID 10706090  0.656
2000 Irvine RA, Ma H, Yu MC, Ross RK, Stallcup MR, Coetzee GA. Inhibition of p160-mediated coactivation with increasing androgen receptor polyglutamine length. Human Molecular Genetics. 9: 267-74. PMID 10607837 DOI: 10.1093/Hmg/9.2.267  0.655
1999 Ma H, Hong H, Huang SM, Irvine RA, Webb P, Kushner PJ, Coetzee GA, Stallcup MR. Multiple signal input and output domains of the 160-kilodalton nuclear receptor coactivator proteins. Molecular and Cellular Biology. 19: 6164-73. PMID 10454563 DOI: 10.1128/Mcb.19.9.6164  0.537
1999 Irvine RA, Coetzee GA. Additional upstream coding sequences of MAGE-11. Immunogenetics. 49: 585. PMID 10380710 DOI: 10.1007/S002510050543  0.407
1997 Ingles SA, Ross RK, Yu MC, Irvine RA, La Pera G, Haile RW, Coetzee GA. Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. Journal of the National Cancer Institute. 89: 166-70. PMID 8998186 DOI: 10.1093/Jnci/89.2.166  0.676
1995 Rubinsztein DC, Leggo J, Coetzee GA, Irvine RA, Buckley M, Ferguson-Smith MA. Sequence variation and size ranges of CAG repeats in the Machado-Joseph disease, spinocerebellar ataxia type 1 and androgen receptor genes. Human Molecular Genetics. 4: 1585-90. PMID 8541843 DOI: 10.1093/Hmg/4.9.1585  0.548
1995 Irvine RA, Yu MC, Ross RK, Coetzee GA. The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer. Cancer Research. 55: 1937-40. PMID 7728763  0.653
Show low-probability matches.